LISCure

LISCure, headquartered in Seoul, South Korea, is a biotechnology and pharmaceutical company. The company focuses on researching bacteria-mediated immunotherapy and developing microbiome-based immune therapeutics to improve patient outcomes. LISCure’s immunotherapy is applicable to cancer, neurodegenerative diseases, autoimmune diseases, and metabolic disorders. This therapy can be used independently for disease treatment or combined with other drugs. Additionally, the company has also entered the nutrition and health supplement industry.